many of your questions were answered- you only listened to what you wanted to hear- hence you have heard nothing!. You cannot claim to be neutral about PRM as your assertions/attitude/accusations do not match that stance. You believe that PRM is overvalued- that is hardly a neutral position.
As regards PRM being a "leaky bucket"- all the information used is in the public domain. If the yankee media and investing public are so blind so as not to appreciate PRM as a leader in developing TSE diagnostic methods, then that is their failing not PRMs. At the end of the day the emergence of in vivo tests for both animal and human TSE expressions will be the paradigm shift- and you cannot deny that PRM appears to be the leader in that race.
I also think that PRM's TSE capability is only a fraction of the company's total worth.